BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10464958)

  • 1. [Value of Markovian nuclear texture to predict progression in surface transitional cell carcinoma of the bladder].
    Alvarez Pérez M; Blanes Berenguel A; García González I; Hierro Martín I; Vicioso Recio L; Matilla Vicente A
    Actas Urol Esp; 1999 Jun; 23(6):497-504. PubMed ID: 10464958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bladder transitional cell carcinoma rating, systematization of grading and value of DNA ploidy].
    Hierro Martín I; Alvarez Pérez M; Blanes Berenguel A; Quiñonero Díaz A; Díaz Cano S; García González I; Matilla Vicente A
    Actas Urol Esp; 1999 Jun; 23(6):489-96. PubMed ID: 10464957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder.
    Decaestecker C; van Velthoven R; Petein M; Janssen T; Salmon I; Pasteels JL; van Ham P; Schulman C; Kiss R
    J Pathol; 1996 Mar; 178(3):274-83. PubMed ID: 8778332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additional predictive value contributed by quantitative chromatin pattern description as compared to DNA ploidy level measurement in 257 superficial bladder transitional cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Raviv G; Janssen T; Roels H; Pasteels JL; Schulman C; Kiss R
    Eur Urol; 1996; 29(2):245-51. PubMed ID: 8647157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques.
    Vaskó J
    Scand J Urol Nephrol Suppl; 1994; 160():1-73. PubMed ID: 7529427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
    Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
    Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of transitional cell bladder carcinoma by image analysis of histological sections.
    Jarkrans T; Vasko J; Bengtsson E; Choi HK; Malmström PU; Wester K; Busch C
    Anal Cell Pathol; 1995 Mar; 8(2):135-58. PubMed ID: 7786812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas.
    Planz B; Striepecke E; Wolff JM; Effert P; Jakse G; Böcking A
    Gen Diagn Pathol; 1996 Oct; 142(2):69-73. PubMed ID: 8950570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
    Jalali Nadoushan MR; Taheri T; Jouian N; Zaeri F
    Urol J; 2007; 4(3):151-4. PubMed ID: 17987577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
    Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
    Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.